Anna Zarra Aldrich '20 (CLAS), Office of the Vice President for Research


Author Archive

UConn Researcher’s Home COVID-19 Test Comparable to PCR Accuracy, Selectivity

A lab-on-paper platform that uses genetic markers to detect the virus even as it mutates

Meet the Researcher: Jacqueline Chen, CLAS

Jacqueline Chen, assistant professor of social psychology, is interested in the experiences of Multiracial people and developing inclusive mentorship strategies

Dr. Cato T. Laurencin in white coat with anatomic model

UConn’s Cato T. Laurencin Engineers Synthetic Artificial Stem Cells; Discovery Opens the Door for Advancement in Regenerative Therapies

A new way to avoid the potential pitfalls of traditional stem cell therapies

NIFA Grant Teaches Youth About Biotechnology, Develops Career Readiness

A new grant will use educational games to teach Connecticut youth about biotechnology and biotechnology careers in agriculture

UConn Health Researcher Investigates Treatment for Eye Injuries from Mass Chemical Weapons Attacks

Royce Mohan will investigate how treatments for sodium hydroxide eye injury could be used to treat similar injuries caused by mustard gas.

Biophysics Core Facility Purchases New State-of-the-Art Instrument

Through a $190,000 S10 NIH Grant, the Biophysics Core Facility purchased a microscale thermophoresis instrument that will support research on drug discovery and understanding diseases.

New Grant Combines Language with Cultural Learning for Students of Korean, Chinese

UConn faculty are launching a program that will use online and in-person learning to improve students' Chinese and Korean language skills

Language & Cognition PhD Program Receives Funding for 5 GAANN Fellows

The UConn program for language and cognition has received funding for five graduate fellows after cognitive psychology and psycholinguistics was identified as an area of national need.

From left, Drs. Xiaofang Wang and Ren-He Xu of ImStem Biotechnology, a UConn spin out developing novel therapies using stem cells, that was recently issued a patent for human embryonic stem cell derived mesenchymal stem cells and the method of producing the stem cells. (Tina Encarnacion/UConn Health File Photo)

TIP Company ImStem Biotechnology Doses First MS Patient in Clinical Trial

UConn TIP company ImSTEM Biotechnology is conducting a clinical trial to test their experimental human embryonic stem cell-derived mesenchymal stem cell therapy for the treatment of multiple sclerosis.

Exterior photograph of the building where UConn's new Stamford Technology Incubation Program is based.

TIP Digital Supports App Promoting Accessibility of Investing for Young People

TIP Digital startup FinTron helps new investors learn about the stock market and get an early start in investing wisely